- Tytuł:
- Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study
- Autorzy:
- Źródło:
- Arthritis Research & Therapy. 20(1)
Czasopismo naukowe